Oxford Nanopore Technologies
Oxford Nanopore Technologies plc is a British biotechnology enterprise headquartered in Oxford, United Kingdom. The company develops and markets innovative molecular sensing technology using nanopore-based DNA/RNA sequencing, which enables real-time, scalable analysis of biological samples. Its platform supports diverse applications in clinical research, epidemiology, food safety, and agriculture. Principal revenue is derived through the sale of proprietary sequencing devices, flow cell consumables, and analytical software licenses to academic and commercial research laboratories globally. Oxford Nanopore Technologies plc is publicly listed on the London Stock Exchange.
6 of the funds FundTelligence covers report a position in Oxford Nanopore Technologies.
- Legal name
- Oxford Nanopore Technologies PLC
- Sector
- Health Care
- Country
- United Kingdom
- Funds holding it
- 6
- Exposure themes
- Genomics & Profiling, Precision Medicine & Genomics, Sequencing
Funds holding Oxford Nanopore Technologies
- T. Rowe Price European Smaller Companies Equity — T. Rowe Price · 0.89 % (full portfolio disclosed, September 2026)
- SEB Läkemedelsfond — SEB · 0.33 % (full portfolio disclosed, June 2026)
- BlackRock iShares Healthcare Innovation UCITS ETF — BlackRock · 0.16 % (full portfolio disclosed, October 2026)
- Handelsbanken Global SMB Index Criteria — Handelsbanken · 0.03 % (full portfolio disclosed, October 2026)
- KLP AksjeGlobal Small Cap Indeks — KLP · 0.01 % (partially disclosed portfolio, June 2026)
- DNB Global Enhanced Small Cap — DNB · 0.0 % (full portfolio disclosed, September 2026)